drugset / Trial / NCT05381207
Impact Of Montelukast On Allergic Rhinitis And Its Inflammatory Makers
RandomizedParallel-groupSingle-blindTreatment
Summary
To examine the efficacy of Montelukast as an adjunct to INCS in patients with allergic rhinitis.
Timeline
- Start
- 2022-10
- Primary completion
- 2024-10
- Completion
- 2024-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Montelukast | Other / unclassified | 10 mg | Oral |
| Comparator | Fluticasone Furoate | Other / unclassified | 100 ug | Intranasal |